Lilly lung cancer drug boosts survival, shares jump
By Reuters
Posted: August 13, 2013 - 3:00 pm ET
Tags:
An experimental Eli Lilly and Co. lung cancer drug, which some investors had given up on due to past setbacks, extended patient survival in a late-stage study, reviving hopes for the medicine and sending company shares 4% higher.
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.